FineVisionHP® (POD F GF),
the first trifocal IOL with the hydrophobic G-free material
95% of patients reach complete spectacle independence at all distances with FineVision® IOL.
97% of patients treated with FineVision® would choose the same IOL again!
*Rafael Bilbao, et al.: Visual outcomes following bilateral implantation of two diffractive trifocal intraocular lenses in 10,084 Eyes, American Journal of Ophthalmology, July 2017.
We contribute to the improvement in the quality of sight, and therefore the life of patients.